Research Analysts’ Weekly Ratings Updates for Revvity (RVTY)

A number of research firms have changed their ratings and price targets for Revvity (NYSE: RVTY):

• 12/15/2025 – Revvity had its “sell (d)” rating reaffirmed by analysts at Weiss Ratings.
• 12/15/2025 – Revvity had its price target raised by analysts at Wells Fargo & Company from $102.00 to $107.00. They now have an “equal weight” rating on the stock.
• 12/15/2025 – Revvity had its price target raised by analysts at Barclays PLC from $105.00 to $115.00. They now have an “overweight” rating on the stock.
• 12/15/2025 – Revvity was downgraded by analysts at Bank of America Corporation from a “buy” rating to a “neutral” rating. They now have a $110.00 price target on the stock.
• 12/9/2025 – Revvity is now covered by analysts at The Goldman Sachs Group, Inc.. They set a “neutral” rating and a $105.00 price target on the stock.
• 12/9/2025 – Revvity is now covered by analysts at The Goldman Sachs Group, Inc.. They set a “neutral” rating and a $105.00 price target on the stock.
• 12/8/2025 – Revvity had its “sell (d)” rating reaffirmed by analysts at Weiss Ratings.
• 12/1/2025 – Revvity had its “sell (d)” rating reaffirmed by analysts at Weiss Ratings.
• 11/25/2025 – Revvity had its “sell (d)” rating reaffirmed by analysts at Weiss Ratings.
• 11/19/2025 – Revvity had its “sell (d)” rating reaffirmed by analysts at Weiss Ratings.
• 11/13/2025 – Revvity had its “sell (d)” rating reaffirmed by analysts at Weiss Ratings.
• 10/28/2025 – Revvity had its price target raised by analysts at Barclays PLC from $100.00 to $105.00. They now have an “overweight” rating on the stock.
• 10/28/2025 – Revvity had its price target raised by analysts at Robert W. Baird from $122.00 to $123.00. They now have an “outperform” rating on the stock.
• 10/27/2025 – Revvity had its “outperform” rating reaffirmed by analysts at Evercore ISI. They now have a $108.00 price target on the stock.
• 10/24/2025 – Revvity was given a new $122.00 price target on by analysts at Robert W. Baird.

Revvity Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Friday, February 6th. Shareholders of record on Friday, January 16th will be paid a $0.07 dividend. The ex-dividend date is Friday, January 16th. This represents a $0.28 annualized dividend and a dividend yield of 0.3%. Revvity’s payout ratio is 14.07%.

Revvity, Inc is a global provider of technology-enabled solutions for the life sciences, diagnostics and applied markets. The company develops and supplies a range of products and services, including reagents and consumables, laboratory instruments, workflow automation, software analytics and technical support. Its portfolio supports applications in drug discovery, genomics, cell biology research, environmental and food safety testing, industrial quality control and clinical diagnostics.

Tracing its heritage to Perkin-Elmer, founded in 1937, Revvity began trading on the New York Stock Exchange under the ticker symbol RVTY in January 2024 following a corporate rebranding.